207 related articles for article (PubMed ID: 22511932)
21. Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.
Deng T; Yuan Y; Zhang C; Zhang C; Yao W; Wang C; Liu R; Ba Y
Cell Physiol Biochem; 2016; 39(5):1716-1722. PubMed ID: 27639768
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease.
Wang J; Chen J; Chang P; LeBlanc A; Li D; Abbruzzesse JL; Frazier ML; Killary AM; Sen S
Cancer Prev Res (Phila); 2009 Sep; 2(9):807-13. PubMed ID: 19723895
[TBL] [Abstract][Full Text] [Related]
23. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
[TBL] [Abstract][Full Text] [Related]
24. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
[TBL] [Abstract][Full Text] [Related]
25. Gene Expression of Col11A1 Is a Marker Not only for Pancreas Carcinoma But also for Adenocarcinoma of the Papilla of Vater, Discriminating Between Carcinoma and Chronic Pancreatitis.
Kleinert R; Prenzel K; Stoecklein N; Alakus H; Bollschweiler E; Hölscher A; Warnecke-Eberz U
Anticancer Res; 2015 Nov; 35(11):6153-8. PubMed ID: 26504042
[TBL] [Abstract][Full Text] [Related]
26. Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma.
Szafranska-Schwarzbach AE; Adai AT; Lee LS; Conwell DL; Andruss BF
Expert Rev Mol Diagn; 2011 Apr; 11(3):249-57. PubMed ID: 21463235
[TBL] [Abstract][Full Text] [Related]
27. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
28. DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma.
Wu Y; Seufert I; Al-Shaheri FN; Kurilov R; Bauer AS; Manoochehri M; Moskalev EA; Brors B; Tjaden C; Giese NA; Hackert T; Büchler MW; Hoheisel JD
Gut; 2023 Nov; 72(12):2344-2353. PubMed ID: 37709492
[TBL] [Abstract][Full Text] [Related]
29. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
[TBL] [Abstract][Full Text] [Related]
30. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
[TBL] [Abstract][Full Text] [Related]
31. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples.
Bournet B; Pointreau A; Souque A; Oumouhou N; Muscari F; Lepage B; Senesse P; Barthet M; Lesavre N; Hammel P; Levy P; Ruszniewski P; Cordelier P; Buscail L
Pancreatology; 2012; 12(1):27-34. PubMed ID: 22487470
[TBL] [Abstract][Full Text] [Related]
32. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.
Sierzega M; Młynarski D; Tomaszewska R; Kulig J
Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582
[TBL] [Abstract][Full Text] [Related]
33. The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer.
Johansen JS; Calatayud D; Albieri V; Schultz NA; Dehlendorff C; Werner J; Jensen BV; Pfeiffer P; Bojesen SE; Giese N; Nielsen KR; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK
Int J Cancer; 2016 Nov; 139(10):2312-24. PubMed ID: 27464352
[TBL] [Abstract][Full Text] [Related]
34. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
[TBL] [Abstract][Full Text] [Related]
35. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis.
Su SB; Qin SY; Chen W; Luo W; Jiang HX
World J Gastroenterol; 2015 Apr; 21(14):4323-33. PubMed ID: 25892884
[TBL] [Abstract][Full Text] [Related]
36. Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis.
Hata T; Ishida M; Motoi F; Yamaguchi T; Naitoh T; Katayose Y; Egawa S; Unno M
Pancreatology; 2016; 16(3):372-81. PubMed ID: 26899542
[TBL] [Abstract][Full Text] [Related]
37. Serum metabolomic analysis of pancreatic cancer--response.
Kobayashi T; Nishiumi S; Yoshida M; Azuma T
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1922. PubMed ID: 24097202
[No Abstract] [Full Text] [Related]
38. Serum metabolomic analysis of pancreatic cancer--letter.
Shakour S; Ruffin MT; Zick SM; Lubman DM; Nie S
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1921. PubMed ID: 24097201
[No Abstract] [Full Text] [Related]
39. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
[TBL] [Abstract][Full Text] [Related]
40. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
